ANIXA BIOSCIENCES, INC. Investment Income, Dividend
ANIXA BIOSCIENCES, INC. (ANIX) reported Investment Income, Dividend of $47.57 thousand for the 12-month period ending 2014-10-31, per its 10-K filed 2015-12-23.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeDividend · last filed 2015-12-23
- ANIXA BIOSCIENCES, INC. investment income, dividend for the quarter ending 2014-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. investment income, dividend for the quarter ending 2014-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. investment income, dividend for the quarter ending 2014-04-30 was $0.00.
- ANIXA BIOSCIENCES, INC. investment income, dividend for the quarter ending 2014-01-31 was $47.57K.
- ANIXA BIOSCIENCES, INC. investment income, dividend for fiscal 2014 was $47.57K.
- ANIXA BIOSCIENCES, INC. investment income, dividend for fiscal 2012 was $13.46K, a 59.82% decline from fiscal 2011.
- ANIXA BIOSCIENCES, INC. investment income, dividend for fiscal 2011 was $33.51K, a 50.88% decline from fiscal 2010.
- ANIXA BIOSCIENCES, INC. investment income, dividend for fiscal 2010 was $68.21K.
| Period end | Investment Income, Dividend 3 month | Investment Income, Dividend 6 month | Investment Income, Dividend 9 month | Investment Income, Dividend 12 month | Investment Income, Dividend 12 month as first filed |
|---|---|---|---|---|---|
| 2014-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $0.00 derived: sum of 2 quarters · filed 2015-12-23 | $0.00 derived: sum of 3 quarters · filed 2015-12-23 | $47.57K 10-K · filed 2015-12-23 | |
| 2014-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $0.00 derived: sum of 2 quarters · filed 2015-08-18 | $47.57K 10-Q · filed 2015-08-18 | ||
| 2014-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | $47.57K 10-Q · filed 2015-05-22 | |||
| 2014-01-31 | $47.57K 10-Q · filed 2015-03-09 | ||||
| 2012-10-31 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | $13.46K derived: sum of 2 quarters · filed 2014-01-17 | $13.46K 10-K/A · filed 2014-01-17 | $13.00K 10-K · filed 2013-01-29 | |
| 2012-07-31 | $13.46K 10-Q/A · filed 2013-09-20 | $13.46K 10-Q/A · filed 2013-09-20 | |||
| 2011-10-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $33.51K derived: sum of 2 quarters · filed 2012-01-30 | $33.51K 10-K · filed 2012-01-30 | ||
| 2011-07-31 | $33.51K 10-Q/A · filed 2011-10-14 | $33.51K 10-Q/A · filed 2011-10-14 | |||
| 2010-10-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $68.21K 10-K · filed 2012-01-30 | |||
| 2010-07-31 | $68.21K 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |